Physician profile
Scott Chapin
NPI 1316988470
$3,006.28
in general payments reported to CMS, 2019-2025
11 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,936 · 2020: $263 · 2021: $114 · 2022: $341 · 2023: $137 · 2024: $114 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $352.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $1,955.50 | 2019-2022 | |
| Merz North America, INC. | $294.88 | 2019 | |
| Galderma Laboratories, L.P. | $294.17 | 2021-2025 | Dysport |
| Allergan, INC. | $289.70 | 2019-2022 | |
| Motiva USA, LLC | $60.28 | 2025 | |
| Mentor Worldwide LLC | $32.76 | 2019 | |
| Davol INC. | $20.09 | 2025 | Galaflex Lite |
| Integra Lifesciences Corporation | $17.40 | 2021 | |
| Coopersurgical, INC. | $14.34 | 2023 | Fisherbrand Disposable Liquid Infant Heel Warmer |
| Seagen INC. | $13.71 | 2019 | |
| Ethicon US, LLC | $13.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Chapin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.